Literature DB >> 17546632

Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction.

Manuela Langbein1, Reiner Strick, Pamela L Strissel, Nicole Vogt, Hans Parsch, Matthias W Beckmann, Ralf L Schild.   

Abstract

Preeclampsia (PE), Hemolysis Elevated Liver Enzymes and Low Platelets (HELLP)-syndrome, and intrauterine growth restriction (IUGR) are associated with abnormal placentation. In early pregnancy, placental cytotrophoblasts fuse and form multinuclear syncytiotrophoblasts. The envelope gene of the human endogenous retrovirus-W, Syncytin, is a key factor for mediating cell-cell fusion of cytotrophoblasts. This study investigated clinical parameters of PE and HELLP-associated IUGR and analyzed the cell-cell fusion index and beta-human chorionic gonadotropin (beta-hCG) secretion of cytotrophoblasts isolated and cultured from placentas of these patients. In addition, we performed absolute quantitation of Syncytin and determined the apoptosis rate in both cultured cytotrophoblasts and placental tissues. Cultured cytotrophoblasts from PE and HELLP-associated IUGR correlated with a pronounced lower cell-cell fusion index, 1.8- and 3.6-fold; less nuclei per syncytiotrophoblast, 1.4- and 2.0-fold; a significantly decreased beta-hCG secretion, 4.3- and 17.2-fold and a reduction of Syncytin gene expression, 8.1 (P = 0.019) and 222.7-fold (P = 0.011) compared with controls, respectively. In contrast, a significantly 2.3-fold higher apoptosis rate was observed in cultured PE/IUGR cytotrophoblasts (P = 0.043). Importantly, Syncytin gene expression in primary placental tissues of PE/IUGR was 5.4-fold lower (P = 0.047) and in HELLP/IUGR 10.6-fold lower (P = 0.019) along with a 1.8- and 1.9-fold significant increase in the apoptosis rate compared with controls, respectively. Low Syncytin expression in both cultured cytotrophoblasts and primary tissues from pathological placentas supports an intrinsic placenta-specific deregulation of cell-cell fusion in the formation of syncytiotrophoblasts leading to increased apoptosis. These processes could contribute to the development and severity of PE and HELLP-associated IUGR. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17546632     DOI: 10.1002/mrd.20729

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  51 in total

1.  Effects of taurine depletion on human placental syncytiotrophoblast renewal and susceptibility to oxidative stress.

Authors:  Michelle Desforges; Hannah Whittaker; Etaoin Farmer; Colin P Sibley; Susan L Greenwood
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene.

Authors:  Anne Dupressoir; Cécile Vernochet; Olivia Bawa; Francis Harper; Gérard Pierron; Paule Opolon; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-29       Impact factor: 11.205

3.  Reduced syncytin-1 expression in choriocarcinoma BeWo cells activates the calpain1-AIF-mediated apoptosis, implication for preeclampsia.

Authors:  Qiang Huang; Haibin Chen; Fengchao Wang; Brian C Brost; Jinping Li; Yu Gao; Zongfang Li; Ya Gao; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2014-01-12       Impact factor: 9.261

4.  Role of LIN28A in mouse and human trophoblast cell differentiation.

Authors:  Jill L Seabrook; Jeremy D Cantlon; Austin J Cooney; Erin E McWhorter; Brittany A Fromme; Gerrit J Bouma; Russell V Anthony; Quinton A Winger
Journal:  Biol Reprod       Date:  2013-10-24       Impact factor: 4.285

5.  Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.

Authors:  Fredrick J Rosario; Yoshikatsu Kanai; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2012-11-19       Impact factor: 5.182

6.  Tissue factor activity in women with preeclampsia or SGA: a potential explanation for the excessive thrombin generation in these syndromes.

Authors:  Offer Erez; Roberto Romero; Edi Vaisbuch; Nandor Gabor Than; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Zhong Dong; Tinnakorn Chaiworapongsa; Chong Jai Kim; Chia-Ling Nhan-Chang; Sun Kwon Kim; Lami Yeo; Moshe Mazor; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-05-19

7.  Trophoblast expression dynamics of the tumor suppressor gene gastrokine 2.

Authors:  Fabian B Fahlbusch; Matthias Ruebner; Hanna Huebner; Gudrun Volkert; Hannah Bartunik; Ilona Winterfeld; Andrea Hartner; Carlos Menendez-Castro; Stephanie C Noegel; Ines Marek; David Wachter; Regine Schneider-Stock; Matthias W Beckmann; Sven Kehl; Wolfgang Rascher
Journal:  Histochem Cell Biol       Date:  2015-06-13       Impact factor: 4.304

8.  Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.

Authors:  Xiaoling Ma; Jinping Li; Brian Brost; Wenjun Cheng; Shi-Wen Jiang
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

Review 9.  Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia.

Authors:  Cynthia S Roland; Jian Hu; Chun-E Ren; Haibin Chen; Jinping Li; Megan S Varvoutis; Lynn W Leaphart; David B Byck; Xueqiong Zhu; Shi-Wen Jiang
Journal:  Cell Mol Life Sci       Date:  2015-10-26       Impact factor: 9.261

10.  Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome.

Authors:  Nandor Gabor Than; Omar Abdul Rahman; Rita Magenheim; Balint Nagy; Tibor Fule; Beata Hargitai; Marei Sammar; Petronella Hupuczi; Adi L Tarca; Gabor Szabo; Ilona Kovalszky; Hamutal Meiri; Istvan Sziller; Janos Rigo; Roberto Romero; Zoltan Papp
Journal:  Virchows Arch       Date:  2008-09-13       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.